- Home
- BSET vs UNCY Comparison
BSET vs UNCY Comparison
Compare BSET & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BSET | UNCY |
|---|---|---|
| Founded | 1902 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.2M | 145.3M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BSET | UNCY |
|---|---|---|
| Price | $14.17 | $6.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $44.50 |
| AVG Volume (30 Days) | 27.3K | ★ 431.9K |
| Earning Date | 04-09-2026 | 04-06-2026 |
| Dividend Yield | ★ 5.63% | N/A |
| EPS Growth | ★ 163.06 | 56.25 |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $456,855,000.00 | $675,000.00 |
| Revenue This Year | $4.94 | N/A |
| Revenue Next Year | $4.03 | N/A |
| P/E Ratio | $20.29 | ★ N/A |
| Revenue Growth | ★ 0.96 | N/A |
| 52 Week Low | $13.70 | $0.45 |
| 52 Week High | $19.75 | $7.57 |
Technical Indicators
Market Signals| Indicator | BSET | UNCY |
|---|---|---|
| Relative Strength Index (RSI) | 34.42 | 49.24 |
| Support Level | $13.70 | $6.48 |
| Resistance Level | $17.24 | $6.82 |
| Average True Range (ATR) | 0.48 | 0.30 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 6.14 | 32.89 |
Price Performance
Historical ComparisonAbout BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.